Corvus Pharmaceuticals
CRVS
#7454
Rank
$0.32 B
Marketcap
$4.99
Share price
-1.96%
Change (1 day)
193.53%
Change (1 year)

Earnings for Corvus Pharmaceuticals (CRVS)

Earnings in 2024 (TTM): -$56.84 Million USD

According to Corvus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -$27.03 Million USD, an increase over its 2022 earnings that were of -$41.31 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corvus Pharmaceuticals from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$56.84 Million110.27%
2023 -$27.03 Million-34.57%
2022 -$41.31 Million-4.47%
2021 -$43.25 Million621.28%
2020 -$6 Million-87.16%
2019 -$46.68 Million-0.57%
2018 -$46.94 Million-15.67%
2017 -$55.67 Million53.03%
2016 -$36.38 Million16.08%
2015 -$31.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$0.14 Billion 137.10%๐Ÿ‡บ๐Ÿ‡ธ USA